Discharge outcomes of intravenous alteplase 4.5-24&#160;hours after symptom onset in selected patients with acute ischemic stroke: a propensity score-matched real-world study.

Activase (alteplase) - Roche, Boehringer Ingelheim, Kyowa Kirin, Tanabe Pharma

http://www.ncbi.nlm.nih.gov/pubmed/42698098

Aichun Cheng; Chunjuan Wang; Jinfeng Yin; Lingshe Meng; Xiyue Cheng; Yingyu Jiang; Yuting Xiong; Zihan Li

Sep 6, 2026